Based on the knockout studies involving p53, coupled with the high incidence of spontaneous Hodgkin’s lymphoma development on the Swiss Jim Lambert mice, we suggest the development of a SMZL murine model with Cav1 LOH with or without an oncogenic driver, such as p53−/− or MYC-Tg. This evidence concerns the gene TP53 and Hodgkins lymphoma.